Evidence map›Paper›PMID 40927661›Full record

ArticleInternational journal of nanomedicine2025

Enhancing Antifungal Efficacy and Stability of Nystatin Liposomes Through Chitosan and Alginate Layer-by-Layer Coating: In vitro Studies Against

Evi Sulastri, Maya Nurul Rahma, Yedi Herdiana, Khaled M Elamin, Ahmed Fouad Abdelwahab Mohammed, Safwat A Mahmoud, Nasrul Wathoni

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evi SulastriDepartment of Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia.
Maya Nurul RahmaDepartment of Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia.
Yedi HerdianaDepartment of Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia.ORCID 0000-0001-5831-9389
Khaled M ElaminGraduated School of Pharmaceutical Science, Kumamoto University, Kumamoto, 862-0973, Japan.ORCID 0000-0001-9555-1814
Ahmed Fouad Abdelwahab MohammedDepartment of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt.
Safwat A MahmoudCenter for Scientific Research and Entrepreneurship, Northern Border University, Arar, 73213, Saudi Arabia.
Nasrul WathoniDepartment of Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia.ORCID 0000-0002-5985-6909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Candidiasis, predominantly caused by Methods: This study aimed to investigate the potential of a layer-by-layer (LBL) coating system, employing chitosan and alginate, to improve the stability, entrapment efficiency (%EE), and antifungal efficacy of nystatin-loaded liposomes against Candida albicans. Nystatin liposomes were synthesized via a thin-film hydration method and subsequently coated with varying ratios of chitosan and alginate using the LBL technique. The optimized formulations were characterized in terms of their particle size, zeta potential, %EE, and morphology. Furthermore, in vitro release dynamics, antifungal activity through Minimum Inhibitory Concentration (MIC) assays, and stability tests at 4°C were conducted. Results: The optimal formulation, designated as NA7-Ch3-Nys-Lip, exhibited a significant improvement in %EE (61.61 ± 1.60% to 83.77 ± 2.00%), enhanced antifungal activity (MIC value of 0.732 µg/mL), and superior stability compared to uncoated liposomes. The LBL system facilitated controlled drug release and maintained desirable particle characteristics under prolonged storage conditions. Conclusion: This study successfully demonstrated that LBL-coated nystatin liposomes significantly enhanced the antifungal activity, stability, and delivery efficiency of the drug. This novel formulation strategy offers a promising approach to overcome the limitations of conventional antifungal therapies, potentially improving the treatment of fungal infections.

Indexed as

AlginatesAntifungal AgentsCandida albicansChitosanLiposomesNystatinDrug LiberationDrug StabilityMicrobial Sensitivity TestsParticle SizeAlginatesAntifungal AgentsChitosanLiposomesNystatinantifungalCandida albicanslayer by layer liposomesnystatin

Identifiers

PMID40927661
PMCPMC12415108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.